Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

Knudsen K, Krack P, Tonder L, Houeto JL, Rau J, Schade-Brittinger C, Hartmann A, Hälbig TD, Paschen S, Barbe MT, Kühn A, Fraix V, Brefel-Courbon C, Vesper J, Maltête D, Sixel-Döring F, Weiss D, Witjas T, Thobois S, Agid Y, Schnitzler A, Schuepbach WMM, Timmermann L, Damier P, Vidailhet M, Deuschl G; EARLYSTIM study group.

Parkinsonism Relat Disord. 2019 Aug;65:217-223. doi: 10.1016/j.parkreldis.2019.05.023. Epub 2019 Jun 18.

PMID:
31257096
2.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

3.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
4.

Reversal learning reveals cognitive deficits and altered prediction error encoding in the ventral striatum in Huntington's disease.

Nickchen K, Boehme R, Del Mar Amador M, Hälbig TD, Dehnicke K, Panneck P, Behr J, Prass K, Heinz A, Deserno L, Schlagenhauf F, Priller J.

Brain Imaging Behav. 2017 Dec;11(6):1862-1872. doi: 10.1007/s11682-016-9660-0.

PMID:
27917451
5.

Levodopa inhibits habit-learning in Parkinson’s disease.

Fuhrer H, Kupsch A, Hälbig TD, Kopp UA, Scherer P, Gruber D.

J Neural Transm (Vienna). 2014 Feb;121(2):147-51.

PMID:
23959161
6.

Neurostimulation for Parkinson's disease with early motor complications.

Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group.

N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158.

7.

Effects of dopaminergic and subthalamic stimulation on musical performance.

van Vugt FT, Schüpbach M, Altenmüller E, Bardinet E, Yelnik J, Hälbig TD.

J Neural Transm (Vienna). 2013 May;120(5):755-9. doi: 10.1007/s00702-012-0923-7. Epub 2012 Dec 12.

PMID:
23232663
8.

Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.

Hälbig TD, Assuras S, Creighton J, Borod JC, Tse W, Frisina PG, Voustianiouk A, Gracies JM, Olanow CW.

Mov Disord. 2011 Aug 1;26(9):1677-83. doi: 10.1002/mds.23728. Epub 2011 Jun 2.

PMID:
21638322
9.

Preserved emotional modulation of motor response time despite psychomotor slowing in young-old adults.

Hälbig TD, Creighton J, Assuras S, Borod JC, Tse W, Gracies JM, Foldi NS, Kaufmann H, Olanow CW, Voustianiouk A.

Int J Neurosci. 2011 Aug;121(8):430-6. doi: 10.3109/00207454.2011.568656. Epub 2011 May 17.

PMID:
21574890
10.

Emotional processing affects movement speed.

Hälbig TD, Borod JC, Frisina PG, Tse W, Voustianiouk A, Olanow CW, Gracies JM.

J Neural Transm (Vienna). 2011 Sep;118(9):1319-22. doi: 10.1007/s00702-011-0627-4. Epub 2011 Apr 26.

PMID:
21519950
11.

Skin picking in Parkinson's disease: a behavioral side-effect of dopaminergic treatment?

Tse W, Hälbig TD.

Psychiatry Clin Neurosci. 2010 Apr;64(2):214. doi: 10.1111/j.1440-1819.2010.02069.x. No abstract available.

12.

The pattern of cognitive-functional decline in elderly essential tremor patients: an exploratory-comparative study with Parkinson's and Alzheimer's disease patients.

Frisina PG, Tse W, Hälbig TD, Libow LS.

J Am Med Dir Assoc. 2009 May;10(4):238-42. doi: 10.1016/j.jamda.2008.10.013. Epub 2009 Apr 2.

PMID:
19426939
13.

Subthalamic deep brain stimulation and impulse control in Parkinson's disease.

Hälbig TD, Tse W, Frisina PG, Baker BR, Hollander E, Shapiro H, Tagliati M, Koller WC, Olanow CW.

Eur J Neurol. 2009 Apr;16(4):493-7. doi: 10.1111/j.1468-1331.2008.02509.x.

PMID:
19236471
14.

The effects of withdrawal of dopaminergic medication in nursing home patients with advanced parkinsonism.

Tse W, Frisina PG, Hälbig TD, Gracies JM, Liang L, Tarshish C, Lesser G, Neufeld R, Koller WC, Libow LS.

J Am Med Dir Assoc. 2008 Nov;9(9):670-5. doi: 10.1016/j.jamda.2008.07.001. Epub 2008 Sep 25.

PMID:
18992700
15.

Levodopa.

Hälbig TD, Koller WC.

Handb Clin Neurol. 2007;84:31-72. doi: 10.1016/S0072-9752(07)84032-2. No abstract available.

PMID:
18808941
16.

Dopaminergic modulation of emotional memory in Parkinson's disease.

Hälbig TD, Kopp UA, Wodarz F, Borod JC, Gracies JM, Ebersbach G, Kupsch A.

J Neural Transm (Vienna). 2008 Aug;115(8):1159-63. doi: 10.1007/s00702-008-0061-4. Epub 2008 May 28.

PMID:
18506391
17.

Prevalence of movement disorders in an elderly nursing home population.

Tse W, Libow LS, Neufeld R, Lesser G, Frank J, Dolan S, Tarshish C, Gracies JM, Olanow CW, Koller WC, Hälbig TD.

Arch Gerontol Geriatr. 2008 May-Jun;46(3):359-66. Epub 2007 Jun 26.

PMID:
17597235
18.

Pallidal stimulation in dystonia: effects on cognition, mood, and quality of life.

Hälbig TD, Gruber D, Kopp UA, Schneider GH, Trottenberg T, Kupsch A.

J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1713-6.

19.

Clinical usefulness of the Parkinson's disease sleep scale.

Tse W, Liu Y, Barthlen GM, Hälbig TD, Tolgyesi SV, Gracies JM, Olanow CW, Koller WC.

Parkinsonism Relat Disord. 2005 Aug;11(5):317-21.

PMID:
15882956
20.

Neuroprotective agents in Parkinson's disease: clinical evidence and caveats.

Hälbig TD, Tse W, Olanow CW.

Neurol Clin. 2004 Oct;22(3 Suppl):S1-S17. Review. No abstract available.

PMID:
15501359
21.

Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD).

Morrison CE, Borod JC, Brin MF, Hälbig TD, Olanow CW.

J Neural Transm (Vienna). 2004 Oct;111(10-11):1333-41. Epub 2004 May 12.

PMID:
15480842
22.

Subthalamic stimulation differentially modulates declarative and nondeclarative memory.

Hälbig TD, Gruber D, Kopp UA, Scherer P, Schneider GH, Trottenberg T, Arnold G, Kupsch A.

Neuroreport. 2004 Mar 1;15(3):539-43. Erratum in: Neuroreport. 2004 Apr 9;15(5):931.

PMID:
15094519
23.

Processing of temporal duration information in working memory after frontodorsal tumour excisions.

Hälbig TD, Yves von Cramon D, Schmid UD, Gall C, Friederici AD.

Brain Cogn. 2002 Nov;50(2):282-303.

PMID:
12464196
24.

Double dissociation of processing temporal and spatial information in working memory.

Hälbig TD, Mecklinger A, Schriefers H, Friederici AD.

Neuropsychologia. 1998 Apr;36(4):305-11.

PMID:
9665641

Supplemental Content

Loading ...
Support Center